Arkadiusz Gajek
8PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 25, 2025
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model.Wiktoria Bębenek, Arkadiusz Gajek, Agnieszka Marczak
|Jan 25, 2025
Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in <i>TP53</i>-Mutated Epithelial Ovarian Cancer Cell Lines.Patrycja Gralewska, Łukasz Biegała, Arkadiusz Gajek
|Aug 10, 2024
Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer.Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak
|May 24, 2024
Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of <i>BRCA2</i><sup>MUT</sup> Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors.Łukasz Biegała, Damian Kołat, Arkadiusz Gajek
|Apr 13, 2023
Olaparib-Resistant <i>BRCA2</i><sup>MUT</sup> Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival.Łukasz Biegała, Arkadiusz Gajek, Agnieszka Marczak
|Jun 24, 2022
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous <i>BRCA</i> and <i>BRCA</i> Ovarian Cancer Cells.Patrycja Gralewska, Arkadiusz Gajek, Dorota Rybaczek
Pageof 2
Frequent Collaborators
8 joint publications
Aneta Rogalska
7 joint publications
Agnieszka Marczak
4 joint publications
Patrycja Gralewska
3 joint publications
Agnieszka Śliwińska
3 joint publications
Łukasz Biegała
2 joint publications
Michał Mikuła
1 joint publications
Piotr Krzeczyński
1 joint publications
Dorota Rybaczek
1 joint publications
Damian Kołat
1 joint publications
Elżbieta Płuciennik
